Retatrutide produces a comprehensive cardiometabolic benefit profile: 14 mmHg blood pressure reduction, substantial lipid improvements, decreased inflammation, and improved insulin sensitivity
BehrJBendstrupECrestaniBGntherAOlschewskiHSkldCet al
13 April 2026 | Monday | News Gan & Lee Pharmaceuticals (hereinafter referred to as "Gan & Lee", SSE: 603087) announced the signing of an exclusive licensing agreement with JW Pharmaceutical, a leading pharmaceutical company in South Korea
Even though most people experience occasional constipation, this condition is sometimes serious and may require medical attention
Wegovy, a medication that contains the same main ingredient, semaglutide, as Ozempic, is FDA-approved for weight loss